Article Information
History
- September 7, 2022.
Article Versions
- Version 1 (July 2, 2022 - 08:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Luigi F. Saccaro, MD1,2,§,*,
- Matteo Tassone, MD3,§,
- Francesca Tozzi4 and
- Grazia Rutigliano, MD PhD3,5
- 1Department of Psychiatry, Faculty of Medicine, University of Geneva, Campus Biotech, 9 Chemin des Mines, 1202 Geneva, Switzerland
- 2Department of Psychiatry, Geneva University Hospital, 1205 Geneva, Switzerland
- 3Department of Pathology, University of Pisa, via Savi 10, 56126 Pisa, Italy
- 4Bio@SNS laboratory, Scuola Normale Superiore, 56124 Pisa, Italy
- 5Institute of Clinical Sciences, Imperial College London, MRI Steiner Unit, Hammersmith Hospital Campus, Du Cane Road, W12 0NN London
- ↵*Correspondence to: Luigi Francesco Saccaro, MD, Department of Psychiatry, Faculty of Medicine, University of Geneva, Campus Biotech, 9 Chemin des Mines, 1202 Geneva, Switzerland, Mobile: +41795531342, e-mail: LuigiFrancesco.Saccaro{at}unige.ch
↵§ These authors equally contributed.
Posted September 07, 2022.
Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: a systematic review and meta-analysis
